Strategy for areas reporting clusters (containment zone) and in large migrationgatherings/evacuees centres as directed by ICMR

Cases of Influenza Like Illness (ILI) to be monitored in health facilities. Any surge in cases to be monitored and brought to the notice of Surveillance Officer/CMO for additional investigation.

 

As a matter of abundant precautions, all symptomatic ILI persons should be advised home quarantine for 14 days.At facility level, symptomatic ILI individuals to be tested using rapid antibody tests.

o Antibody test negative:

 If warranted, confirm by real-time RT-PCR using throat/nasal swab.

ï‚· RT-PCR negative: Likely non-COVID-19 ILI

ï‚· RT-PCR positive: Confirmed COVID-19 Case and action as per protocol to be

initiated for isolation, treatment and contact tracing.

OR

 If real-time RT-PCR not done, home quarantine and repeat antibody testing after 10

days of the last rapid antibody test.

ï‚· Antibody test negative: Likely non-COVID-19 ILI.

ï‚· Antibody test positive: there is possibility of recent infection, quarantine for

another 10 days.

o Antibody test positive: After clinical assessment, treatment in hospital or isolation as per

protocol. Action as per protocol to be initiated for contact tracing.

If symptoms worsen, refer to designated COVID-19 hospitals.

When home quarantine is not feasible, consider facility-based quarantine.